Skip to menu Skip to content Skip to footer

2004

Journal Article

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

Barter, P., Best, J., Colman, P., d'Emden, M., Davis, T., Drury, P., Ehnholm, C., Glasziou, P., Hunt, D., Keech, A., Kesaniemi, Y. A., Laakso, M., Scott, R., Simes, R. J., Sullivan, D., Taskinen, M-R, Whiting, M., Ansquer, J-C, Fraitag, B., Anderson, N., Hankey, G., Hunt, D., Lehto, S., Mann, S., Romo, M., Li, L. P., Hennekens, C., MacMahon, S., Pocock, S. ... Aubonnet, P. (2004). The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]. Cardiovascular Diabetology, 3 (1) 9. doi: 10.1186/1475-2840-3-9

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]